Form 4: Amneal Pharmaceuticals Director Gautam Patel Sells 80,000 Shares

Director Gautam Patel of Amneal Pharmaceuticals sold 80,000 shares of Class A Common Stock at an average price of $8.3 on April 1, 2025, according to a Form 4 filing.

Summary

• Gautam Patel, a director at Amneal Pharmaceuticals, sold 80,000 shares of Class A Common Stock on April 1, 2025.
• The sale was executed at a weighted average price of $8.3 per share, with individual transactions ranging from $8.17 to $8.43.
• The transaction was conducted under a pre-arranged trading plan adopted on August 15, 2024, compliant with Rule 10b5-1(c).
• Following the sale, Patel directly owns 1,728,886 shares of Amneal Pharmaceuticals.
• The sale was reported on a Form 4 filing with the Securities and Exchange Commission.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing reporting a stock sale by a company director. It doesn't inherently convey positive or negative sentiment.

Industry Context

Form 4 filings are standard practice for reporting transactions by company insiders, providing transparency to the market.

Stakeholder Impact

• The sale of shares by a director could be perceived neutrally or slightly negatively by shareholders, depending on the context and reasons for the sale.

Key Dates

Keywords

Amneal Pharmaceuticals, Gautam Patel, Form 4, Stock Sale, Insider Trading, AMRX, Director, Class A Common Stock, Rule 10b5-1(c)